Shilajit versus placebo in the management of patients with moderate coronavirus disease 2019: A triple-blind randomized controlled trial protocol.

Authors
Category Primary study
JournalAdv. Integr. Med.
Year 2025
This article has no abstract
Epistemonikos ID: 32462997e597f45c49170372f84c972ae251c546
First added on: May 17, 2025